Antiretroviral kombinationsbehandling (CART), også REYATAZ- baseret kombinationsbehandling (med eller uden ritonavir), er forbundet med dyslipidæmi.
Combination antiretroviral therapy (CART), including REYATAZ (with or without ritonavir)-based CART, is associated with dyslipidaemia.